What Does The UK’s ‘Flexible’ Approach To AI Regulation Mean For Pharma?

The UK government says that its non-legislative approach to AI regulation will promote innovation and allow it to react quickly to changes in the ecosystem. But a life sciences lawyer warns that creating an uncertain regulatory environment could be problematic.